Timothy C.  Wentworth net worth and biography

Timothy Wentworth Biography and Net Worth

TIMOTHY C. WENTWORTH, 60, Chief Executive Officer, Evernorth beginning September 2020; President, Health Services from February 2020 until September 2020; President, Express Scripts and Cigna Services from December 2018 until February 2020; Chief Executive Officer of Express Scripts from May 2016 until December 2018; President from February 2014 through December 2018; and Seni Tim Wentworth serves as the Chief Executive Officer of Evernorth. Prior to this role, Wentworth served as President, Express Scripts and Cigna Services. Prior to the Cigna/Express Scripts combination in 2018, Wentworth served as President and CEO of Express Scripts, where he was responsible for all aspects of the company’s strategic direction and core business. He joined Express Scripts when the company merged with Medco in April 2012. At Medco, he led the employer and key accounts organizations for nearly 14 years. He also served as President and CEO of Accredo, the company's specialty pharmacy.

Wentworth earned a bachelor's degree in industrial and labor relations from Cornell University and an associate's degree in business from Monroe Community College.

or Vice President and President, Sales and Account Management from April 2012 until February 2014.

What is Timothy C. Wentworth's net worth?

The estimated net worth of Timothy C. Wentworth is at least $54.02 million as of January 5th, 2024. Mr. Wentworth owns 585,122 shares of Express Scripts stock worth more than $54,024,314 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Wentworth may own. Learn More about Timothy C. Wentworth's net worth.

How old is Timothy C. Wentworth?

Mr. Wentworth is currently 58 years old. There are 4 older executives and no younger executives at Express Scripts. Learn More on Timothy C. Wentworth's age.

How do I contact Timothy C. Wentworth?

The corporate mailing address for Mr. Wentworth and other Express Scripts executives is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. Express Scripts can also be reached via phone at 314-996-0900 and via email at [email protected]. Learn More on Timothy C. Wentworth's contact information.

Has Timothy C. Wentworth been buying or selling shares of Express Scripts?

Timothy C. Wentworth has not been actively trading shares of Express Scripts during the last quarter. Most recently, on Tuesday, October 31st, Timothy C. Wentworth bought 8,000 shares of Express Scripts stock. The stock was acquired at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now directly owns 98,628 shares of the company's stock, valued at $6,029,129.64. Learn More on Timothy C. Wentworth's trading history.

Who are Express Scripts' active insiders?

Express Scripts' insider roster includes Phyllis Anderson (VP), James Havel (Exec. VP & CFO ), Christine Houston (Insider), Christopher McGinnis (VP), Everett Neville (VP), Glen Stettin (VP), and Timothy Wentworth (CEO). Learn More on Express Scripts' active insiders.

Timothy C. Wentworth Insider Trading History at Express Scripts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/31/2017Buy8,000$61.13$489,040.0098,628View SEC Filing Icon  
See Full Table

Timothy C. Wentworth Buying and Selling Activity at Express Scripts

This chart shows Timothy C Wentworth's buying and selling at Express Scripts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Express Scripts Company Overview

Express Scripts logo
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $92.33
Low: $92.11
High: $95.87

50 Day Range

MA: $92.33
Low: $92.33
High: $92.33

2 Week Range

Now: $92.33
Low: $66.93
High: $101.73

Volume

31,612,912 shs

Average Volume

6,636,970 shs

Market Capitalization

$52.06 billion

P/E Ratio

13.00

Dividend Yield

N/A

Beta

0.88